← Leaderboards
Shashi Kapadia
Weill Medical Coll Of Cornell Univ
$4,528,330
Attributed
$4,528,330
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,528,330 · 3
By mechanism
R01$3,580,041 · 2
K01$948,289 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Martin F Shapiro$11,123,560
- Manney Carrington Reid$15,232,004
- Joshua Ryan Vest$5,635,835
- Jyoti S Mathad$5,324,297
- Robert E Schwartz$8,769,705
Others in their field
Other Emerging Leaders on “Injection Drug Use”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Xinhua Li · Nano Terra, Inc.$24,014,067
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
- Vera Hoffman · Reveal Pharma$11,443,120
- Soumya Rahima Benhabbour · Univ Of North Carolina Chapel Hill$11,411,217
Research focus
Injection Drug UseInjecting Drug UserSubstance Use DisorderPublic HealthUptakeDrug UserCaringAffectPoliciesMedicaidPositioning AttributeProgramsHepatitis CDesignProviderAreaMortalityMedical SpecialtiesUnited StatesInterviewCessation Of LifeTrainingHealthcareHepatitis C Therapy
Grant awards (11)
Universal HCV screening in pregnancy: Examining testing uptake and HCV care$731,960
R01 · FY2025 · DA · contact PI
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections$680,423
R01 · FY2025 · DA · contact PI
Universal HCV screening in pregnancy: Examining testing uptake and HCV care$707,647
R01 · FY2024 · DA · contact PI
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections$707,109
R01 · FY2024 · DA · contact PI
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections$752,902
R01 · FY2023 · DA · contact PI
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment$172,410
K01 · FY2023 · DA · contact PI
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment$172,410
K01 · FY2022 · DA · contact PI
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment$172,410
K01 · FY2021 · DA · contact PI
Inequities in the epidemiology and treatment of HCV and other injection-related infections in a national sample of Medicaid enrollees$86,239
K01 · FY2021 · DA · contact PI
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment$172,410
K01 · FY2020 · DA · contact PI
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment$172,410
K01 · FY2019 · DA · contact PI